Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66689 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-03-10 | 2021-07-08 | 108347 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62789 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-03-10 | 2021-02-10 | 108341 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| IRBESARTAN | 150MG | TABLET | Actual shortage | 2024-11-25 | 2025-01-04 | 243729 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| IRBESARTAN | 300MG | TABLET | Actual shortage | 2024-11-25 | 2025-02-15 | 243736 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-10 | 2019-11-28 | 86038 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| AVAPRO | 75MG | TABLET | Discontinued | 2024-05-31 | 2025-01-15 | 229306 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
| MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |